期刊文献+

各项凝血指标在肝硬化患者诊治中的临床意义评估 被引量:1

Clinical value of coagulation index in liver cirrhosis diagnosis and treatment
原文传递
导出
摘要 目的:通过凝血实验室指标与临床病症的紧密结合,对肝硬化患者的诊断治疗和病情监测进行研究和分析。方法:对临床确诊的12例肝硬化代偿组(LC-1)、67例肝硬化失代偿组(LC-2)和健康对照组(N)进行PT、PA、APTT、FIB、V、VⅡ、VⅢ、DD及PLT的测定和分析。结果:1.肝硬化失代偿患者(LC-2)PT、PA、APTT、FIB、V、VⅡ、DD及PLT水平与N组比较均存在显著性差异(P<0.001);LC-2组与LC-1组比较,PT、PA、APTT、V、VⅡ、FIB水平存在显著性差异(P<0.01);2.肝硬化失代偿患者PA与VⅡ相关性最高(r=0.66);3.DD、V和VⅡ在肝硬化有腹水组和无腹水组之间均具有极显著性差异(P<0.001)。结论:1.DD、PT、PA、APTT、FIB、V、VⅡ、PLT水平对LC-2具有很好的诊断价值。2.PT、PA、APTT、V、VⅡ、FIB对LC-1与LC-2具有一定的鉴别价值。3.DD、V和VⅡ对肝硬化有腹水组和无腹水组具有一定的预测价值。4.DD、V、VⅡ和APTT对肝硬化的早期诊断、分期和预后具有重要的价值,应该加强其在临床的应用。 Objective: To study the clinical value of coagulation index in diagnosis,treatment and condition-observation in patients with liver cirrhosis.Methods:12 stable cirrhosis(LC-1),67 advanced cirrhosis(LC-2) and 19 healthy persons(N)were collected.PT,PA,APTT,FIB,F,VⅡ,VⅢ,DD and PLT were detected.Results:1.The difference of DD,PT,PA,APTT,FIB,V,VⅡ,PLT in LC-2 compared with N group were all statistically significant.2.VⅡ correlated the best with PA in patientswith LC-2.3.The differences of DD,V,VⅡ between ascites and non-ascitesl were statistically significant.Conclusion:1.DD,PT,PA,APTT,FIB,V,VⅡ,PLT have a better diagnostic value for LC-2.2.PT,PA,APTT,V,VⅡ,FIB have some extent of differential value for LC-1 and LC-2 3.DD,V and VⅡ have some extentof predictable value for ascites 4.DD,V,VⅡ and APTT have important value for early-diagnosis and prognosis in liver cirrhosis.
出处 《中国卫生检验杂志》 CAS 2009年第8期1836-1838,共3页 Chinese Journal of Health Laboratory Technology
关键词 肝硬化 凝血指标 Liver cirrhosis Coagulation index
  • 相关文献

参考文献5

二级参考文献27

  • 1Durand F, Bemuau J, Pessayre D, et al. Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazid. Hepatology,1995,21:929-932.
  • 2Pereira LM, Langley PG, Haynar KM, et al. Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators.Gut,1992,33:98-102.
  • 3Bismuth H, Samuel D, Castaing D, et al. Orthotopic liver transplantation in fulminant and subfulminant hepatitis .The Paul Brousse experience.Ann Surg, 1995,222 : 109-119.
  • 4Durand F, Samuel D, Bemuau J, et al. Fipexide-induced fulminant hepatitis .Report of three cases with emergency liver transplantation .J Hepatol,1992, 15:144-146.
  • 5王鸿利,临床血液学杂志,1989年,2卷,49页
  • 6王鸿利,中华传染病杂志,1989年,7卷,132页
  • 7沈迪,临床血液学,1989年
  • 8王振义,血栓与止血.基础与临床,1988年
  • 9王鸿利,血栓与止血检验技术,1987年
  • 10卢兴国,国外医学流行病学传染病学分册,1983年,10卷,208页

共引文献141

同被引文献4

  • 1潘新福,张栩,张洁.凝血酶原时间测定在乙型病毒性肝炎患者中的临床应用[J].中国感染控制杂志,2005,4(3):242-244. 被引量:6
  • 2中国中西医结合研究会活血化瘀专业委员会.血瘀证诊断标准[J].中西医结合杂志,1987,(3):129-129.
  • 3陈灏珠.实用内科学[M].11版.北京:人民卫生出版社,2002:1784.
  • 4Ballmer PE,Reichen J,McNurlan MA,et al.Albumin but Not Fibrinogen synthesis correlater with galactose elimination capacity in patients with cirrhosis of the liver[J].Hepatology,1996:24:53-59.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部